Mark C. Throdahl
Known title: DirectorCIK: 0001439415
Associated companies
Transaction History
| KIDS | ▲ Buy | Grant | 11,436 | $0 | 6/9/2026 | View on chart |
| KIDS | ▲ Buy | Grant | 8,401 | $0 | 5/23/2025 | View on chart |
| KIDS | ▲ Buy | Grant | 21,623 | $0 | 6/11/2024 | View on chart |
| KIDS | ▼ Sell | Open Market | 2,433 | $67K | 3/11/2024 | View on chart |
| KIDS | ▲ Buy | Grant | 12,266 | $0 | 3/15/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 4,515 | $198K | 3/6/2023 | View on chart |
| KIDS | ▲ Buy | Grant | 10,363 | $0 | 3/15/2022 | View on chart |
| KIDS | ▼ Sell | Open Market | 5,961 | $349K | 3/2/2022 | View on chart |
| KIDS | ▼ Sell | Gift | 3,000 | $0 | 12/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
OrthoPediatrics Reports 1,000th PNP Nail Implantation
OrthoPediatrics announced that its PNP Tibia Nail has reached 1,000 implantations, a milestone highlighting product adoption. Separately, the company is listed among stocks seeing action from activist investors. These developments provide context for the stock's current position within its 52-week range.
OrthoPediatrics Reports 1,000th PNP Nail Implantation. OrthoPediatrics announced that its PNP Tibia Nail has reached 1,000 implantations, a milestone highlighting product adoption. Separately, the company is listed among stocks seeing action from activist investors. These developments provide context for the stock's current position within its 52-week range.